Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Baudax Bio, Inc. (BXRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 8-K Quarterly results
10/11/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
10/10/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
10/06/2023 8-K Investor presentation
Docs: "Investor Presentation of Baudax Bio, Inc.",
"Investor Presentation of Baudax Bio, Inc."
09/29/2023 8-K Quarterly results
08/25/2023 PRER14A Form PRER14A - Preliminary Proxy Soliciting materials:
08/25/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
Docs: "Purchase Agreement, between Baudax Bio, Inc. and Alumni Capital LP"
08/24/2023 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs: "Certificate of Designation of Preferences, Rights and Limitations of Series C Preferred Stock",
"Certificate of Designation of Preferences, Rights and Limitations of Series C Preferred Stock"
08/24/2023 8-A12G Form 8-A12G - Registration of securities [Section 12(g)]:
08/21/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/21/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modifications to Rights of Secu...
Docs: "Opinion of Goodwin Procter LLP",
"Form of Series E Pre-funded Warrant",
"Form of Series A-7 Warrant",
"Opinion of Goodwin Procter LLP",
"Form of Securities Purchase Agreement"
08/18/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
08/17/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
08/16/2023 8-K Quarterly results
Docs: "Baudax Bio Reports Second Quarter 2023 Financial Results and Provides Business Update"
08/16/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/15/2023 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
08/09/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/09/2023 8-K/A Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Business Section of Baudax Bio, Inc",
"Risk Factors of Baudax Bio, Inc"
07/31/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
07/31/2023 8-K/A Quarterly results
07/31/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
07/25/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
07/25/2023 8-K Quarterly results
07/17/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
07/17/2023 8-K Quarterly results
07/13/2023 3 Kim Yong Chan (Director) has filed a Form 3 on Baudax Bio, Inc.
07/10/2023 SC 13G/A BLACK HORSE CAPITAL LP reports a 6.9% stake in Baudax Bio Inc.
07/05/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
07/05/2023 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity ...
Docs: "Agreement and Plan of Merger, by and among Baudax Bio, Inc., Bounce Merger Sub I, Inc., Bounce Merger Sub II, LLC and TeraImmune, Inc.",
"Certificate of Designations of Series X Non-Voting Convertible Preferred Stock",
"Forbearance Agreement, by and among Baudax Bio, Inc, Baudax Bio N.A. LLC, Baudax Bio Limited, Wilmington Trust, National Association, and the Lender party hereto"
06/28/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
06/28/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the registration statements on Form S-3, in the registration statements on Form S-8 and in the registration statements on Form S-1 of our report dated March 16, 2022, except for Note 4, as to which the date is June 28, 2023 with respect to the consolidated financial statements of Baudax Bio, Inc. /s/ KPMG LLP Philadelphia, Pennsylvania June 28, 2023",
"CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statements of Baudax Bio, Inc. on Form S­3 . 333-235408, 333-243488 and 333-253117), Form S­8 . 333-235377, 333-253118, 333-253120, 333-263606 and 333-263608) and Form S-1 . Nos. 333-266499, 333-268251 and 333-271161) of our report dated February 23, 2023, except for Note 4, as to which the date is June 28, 2023, on our audit of the financial statements as of December 31, 2022 and for the year then ended, and the retrospective adjustments to the 2021 financial statements discussed in Notes 1 and 3 to the financial statements.. Our report includes an explanatory paragraph about the existence of substantial doubt concerning the Company's ability to continue as a g..."
05/19/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
05/12/2023 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Baudax Bio Reports First Quarter Financial Results and Provides Business Update"
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy